Throughout 2022, we celebrated the 50th anniversary of CIBMTR® (the Center for International Blood and Marrow Transplant®). Cellular therapy has come a long way from its roots in the Cold War of the 1950s, from an experimental treatment for radiation sickness to a standard therapy for leukemia, lymphoma and sickle cell disease. Now, cellular therapy includes both blood and marrow transplantation and other adoptive cellular therapies.
The story began in 1972, when a handful of doctors from the US, France, and the Netherlands created an international registry of transplants in order to see which therapies helped people the most. Over time, this informal alliance grew to involve many more countries and a formal research collaboration between the Medical College of Wisconsin (MCW) and the National Marrow Donor Program® (NMDP)/ Be The Match®.
Today, CIBMTR receives data from about 350 medical centers worldwide and has analyzed clinical outcomes of 600,000 people who underwent blood and marrow transplantation. Recently, CIBMTR expanded to collect data for other cell therapies, such as chimeric antigen receptor T cell (CAR-T) therapy.
To mark the 50th anniversary, CIBMTR developed a timeline, capturing some key moments from the past 50 years. Click on the image below to view the timeline.